Navigation Links
Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival

itions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were discovered and developed internally. For more information, please see www.syntapharma.com

Conference Call and Webcast

Synta will hold a conference call at 2:30 p.m. (ET) today to discuss the positive overall survival and sub-population data from the Phase 2b clinical trial of STA-4783. This data will also be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois this morning.

The conference call will be webcast live over the Internet. The webcast can be accessed by logging on to the "Investors" section of Synta Pharmaceuticals' website, www.syntapharma.com, prior to the event.

The call also can be accessed by dialing (877) 407-8035 or (201) 689-8035 prior to the start of the call. Following the call, the webcast will be archived on the Company's website.

Safe Harbor Statement

This media release may contain forward-looking statements about Synta Pharmaceuticals Corp. Such forward-looking statements can be identified by the use of forward-looking terminology such as "will," "would," "should," "expects," "anticipates," "intends," "plans," "believes," "may," "estimates," "predicts," "projects," or similar expressions intended to identify forward-looking statements. Such statements, including statements relating to the timing and progress of clinical trials of STA-4783, reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including that the results of completed clinical trials may not nece
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Synta Pharmaceuticals to Host Conference Call Today
2. Synta Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the ASCO Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:7/21/2014)... Israel , July 21, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that it ... July 25, 2014 to discuss results for the period ... on current developments with respect to its clinical program ...
(Date:7/21/2014)... 2014   Aventura , the leader for ... today that MemorialCare Health System , a ... solution at the Orange Coast Memorial Medical ... Orange Coast Memorial is a 218-bed general ... patients annually. The Aventura Roaming Aware Desktop (RAD) ...
(Date:7/21/2014)... 21, 2014  A new Journal of the ... and scheduled to appear in the August 13 print ... new Hepatitis C Virus (HCV) treatments such as Sovaldi ... CVS Caremark (NYSE: CVS ) Chief Medical ... William Shrank , M.D., suggest that the discussion ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
(Date:7/22/2014)... With over 170,000 students now playing high school ... during practice and competition, according to a new study ... Center for Injury Research and Policy at Nationwide Children,s ... today by The American Journal of Sports Medicine ... injuries over the four academic years from 2008 through ...
(Date:7/22/2014)... 2014 Garland’s new Energizer BK ... be used as a flood coat over new and ... a premium restoration material. It provides natural resistance to ... and reducing life-cycle costs. Energizer BK is specially formulated ... water resistance in addition to superior strength and flexibility. ...
(Date:7/22/2014)... CareTouch Communications, Inc. has formed a new ... . CareTouch employees will select causes they are passionate ... line with their mission to help people in and ... cause is Hike for Hospice, to benefit the Butterfly ... 14, the CareTouch in the Community team will climb ...
(Date:7/22/2014)... 2014 Most people encounter the same two problems ... and the second is a fast metabolism. These are hard problems ... provides ways to help fight these problems and to finally gain ... people out there who just can’t seem to eat more than ... are full. The cause of this problem can vary. For some ...
(Date:7/22/2014)... 22, 2014 A new and technologically ... laxity with results that are surprising even the most ... the skin with radio frequency, ThermiTight has been dubbed ... under the skin to “inject” heat to the tissues ... this single treatment solution for skin laxity produces results ...
Breaking Medicine News(10 mins):Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CareTouch is a Peak Sponsor for the 9th Annual Hike for Hospice in Morrison, Colorado 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2
... report by the public services watchdog, the hospitals in Scotland ... with potentially// fatal condition known as ‘Deep vein thrombosis’ (DVT), ... the leg. ,An enquiry that was conducted in ... DVT, found that the failure to diagnose the condition had ...
... other form of treatment. But to a benefit of all GPs ... ,A resident artist much like resident doctors has been ... Susan Grant, a graduate of the Edinburgh School of Art. ... Council. ,It is one of 27 projects across Scotland ...
... It’s all wired at birth. Even the sex drive, researchers say. ... work to cure 'sex addicts'// , for the answer lies in ... more driven than others in seeking carnal pleasures. ,We ... University of the Negev in Israel. ,The scientists say ...
... bird flu in humans, a senior doctor in Moscow has ... but avian influenza in birds has claimed around 1.1 million ... have started tests on 120 volunteers," said Vitaly Zverev, the ... are mainly medical staff, doctors and donors. They are all ...
... plan to expand joint research into oral and throat ... ,The cooperation between Singapore's National Cancer Centre (NCC) and ... programme credited with cutting the death rate from mouth ... percent. ,The new joint effort, signed Monday, ...
... was found that people who were in their sixties have ... in an increase in the rates of cosmetic surgery. The ... among the procedures used in these surgeries. Statistics show ... of men and women in their sixties having cosmetic surgery ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
Medicine Products: